Belite Bio, Inc. Sponsored ADR

BLTE Healthcare Biotechnology

EPS
−40.0%
Free cash flow
+64.7%

Quarter to June 2026, against a year earlier

154.46 11.27 +7.87%
Market cap
$5.8B
P/E
0.0×
Fwd P/E
—
Dividend yield
—
F-score
n/a
Altman Z
n/a
Beneish M
n/a
Dividend safety
n/a

Belite Bio, Inc. Sponsored ADR (BLTE) Operating margin

Alert me on Operating margin

Belite Bio, Inc. Sponsored ADR's operating margin over the twelve months to 30 June 2026 was 0.00%, down 0.0 percentage points from fiscal 2025 (0.00%). Over the past ten years it has ranged from 0.00% (fiscal 2025) to 0.00% (fiscal 2025) — the current reading is the highest in ten years. That is in line with the Biotechnology industry median of 0.00% and in line with the Healthcare sector median of 0.00%.

Operating margin, annual

Embed this chart

Annual newest first

Period Operating margin Change (points)
FY2025 0.00% 0.00
FY2024 0.00% 0.00
FY2023 0.00% 0.00
FY2022 0.00% 0.00
FY2021 0.00% 0.00
FY2020 0.00% —

Quarterly newest first

Period Operating margin Change (points)
Jun 2026 0.00% 0.00
Mar 2026 0.00% 0.00
Dec 2025 0.00% 0.00
Sep 2025 0.00% 0.00
12 more quarters

Against its own ten years

Low 0.00% High 0.00%
Ten-year median 0.00%
Current reading's percentile 100

Operating margin against peers

Company Operating margin
PTCT PTC Therapeutics, Inc. compare 12.8%
LGND Ligand Pharmaceuticals Incorporated compare 9.29%
KOD Kodiak Sciences Inc. compare 0.00%
ORKA Oruka Therapeutics, Inc. compare 0.00%
IMVT Immunovant, Inc. compare 0.00%
BLTE Belite Bio, Inc. Sponsored ADR 0.00%
IONS Ionis Pharmaceuticals, Inc. compare −68.0%
MIRM Mirum Pharmaceuticals, Inc. compare −133.6%
CGON CG Oncology, Inc. compare −4,056.2%
Biotechnology industry median 0.00%
Healthcare sector median 0.00%
Market median 0.00%

What Operating margin is

EBIT Margin tells an investor how much operating profit, before interest and taxes, a company keeps from each unit of revenue.

EBIT ÷ Revenue

The full definition of Operating margin →

More on BLTE